SALVATORE, Giuliana
 Distribuzione geografica
Continente #
NA - Nord America 6.251
EU - Europa 3.872
AS - Asia 1.030
SA - Sud America 94
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 13
OC - Oceania 4
Totale 11.284
Nazione #
US - Stati Uniti d'America 6.242
RU - Federazione Russa 1.546
UA - Ucraina 670
VN - Vietnam 378
IT - Italia 350
SG - Singapore 349
SE - Svezia 344
GB - Regno Unito 287
DE - Germania 275
CN - Cina 246
FR - Francia 143
FI - Finlandia 82
BR - Brasile 79
NL - Olanda 77
EU - Europa 19
BE - Belgio 15
PL - Polonia 15
IE - Irlanda 13
AT - Austria 12
CZ - Repubblica Ceca 11
HK - Hong Kong 9
TR - Turchia 7
CA - Canada 5
IN - India 5
AR - Argentina 4
KR - Corea 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BG - Bulgaria 3
EC - Ecuador 3
IL - Israele 3
JP - Giappone 3
MA - Marocco 3
MX - Messico 3
PE - Perù 3
PK - Pakistan 3
RO - Romania 3
ZA - Sudafrica 3
AM - Armenia 2
AU - Australia 2
CH - Svizzera 2
DK - Danimarca 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
LK - Sri Lanka 2
LV - Lettonia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
UZ - Uzbekistan 2
VE - Venezuela 2
AL - Albania 1
BT - Bhutan 1
BY - Bielorussia 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ES - Italia 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
MC - Monaco 1
MK - Macedonia 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.284
Città #
Fairfield 965
Woodbridge 707
Houston 587
Chandler 454
Ann Arbor 444
Ashburn 398
Seattle 395
Dong Ket 377
Wilmington 377
Cambridge 327
Moscow 272
Nyköping 220
Dearborn 207
Singapore 200
Jacksonville 177
Boardman 157
Southend 146
Napoli 76
Beijing 72
Naples 71
Princeton 70
Lawrence 64
Groningen 63
Grafing 59
Yubileyny 58
Ogden 52
New York 49
Shanghai 40
Munich 38
San Diego 36
The Dalles 32
Helsinki 29
Düsseldorf 26
Des Moines 24
Formia 23
Milan 21
Los Angeles 18
Jinan 17
Norwalk 17
London 16
Lauterbourg 15
Brussels 14
Hefei 14
Kunming 13
Boydton 12
Auburn Hills 11
Dublin 11
Kraków 11
Dallas 10
Nanjing 10
Redmond 9
Afragola 8
Bremen 8
Edinburgh 8
Hong Kong 8
Nocera Inferiore 8
Redwood City 8
São Paulo 8
Brno 7
Rome 7
Vienna 7
Shenyang 6
Amsterdam 5
Atlanta 5
Casoria 5
Guangzhou 5
Kilburn 5
Nanchang 5
Nocera Superiore 5
St Louis 5
Stockholm 5
Hangzhou 4
Matawan 4
Nuremberg 4
Portsmouth 4
Shenzhen 4
Zhengzhou 4
Altavilla Irpina 3
Baku 3
Chongqing 3
Costa Mesa 3
Frankfurt am Main 3
Fuzhou 3
Giugliano in Campania 3
Kocaeli 3
Lisbon 3
Olomouc 3
Pescara 3
Santa Clara 3
Sofia 3
Tokyo 3
Wandsworth 3
Warsaw 3
Wuhan 3
Acton 2
Agropoli 2
Antwerp 2
Assisi 2
Athens 2
Baotou 2
Totale 7.726
Nome #
Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer 313
TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells 270
Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 α/β pathways 245
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma 238
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer 237
Unveiling the miRNAs responsive to physical activity/exercise training in cancer: A systematic review 236
Long-term recreational football training and health in aging 231
Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells 213
Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. 212
Anaplastic Thyroid Carcinoma: Molecular Tools for Diagnosis and Therapy 209
Identification of polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma 209
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells 205
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma 204
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 198
Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer 195
BAY 43-9006 inhibition of oncogenic RET mutants. 194
miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA 193
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma 189
A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. 188
Analysis of BRAF Point Mutation and RET/PTC Rearrangement Refines the Fine-Needle Aspiration Diagnosis of Papillary Thyroid Carcinoma 184
BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma 183
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes 183
High-Frequency Ultrasound-Guided Injection for the Generation of a Novel Orthotopic Mouse Model of Human Thyroid Carcinoma 180
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1) 179
Identification of targets of twist1 transcription factor in thyroid cancer cells. 178
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas 176
Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins 174
Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia 171
Receptor tyrosine kinase inhibitors in thyroid cancer 171
Different mutations of the RET gene cause different human tumoral diseases 171
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas 170
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma 165
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase 162
DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins 161
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells 161
Dissecting the molecular pathways involved in the effects of physical activity on breast cancers cells: A narrative review 161
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 155
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. 155
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness 154
PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach 151
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins 151
MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer 149
Identification of a novel subtype of H4-RET rearrangement in a thyroid papillary carcinoma and lymph node metastasis 149
Morphological ultrasound microimaging of thyroid in living mice 147
High Frequency Ultrasound for the development of an Orthotopic mouse model of Human Follicular Thyroid Carcinoma 143
Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice. 143
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 142
Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas 140
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype 137
Presence of BRAF V600E in Very Early Stages of Papillary Thyroid Carcinoma 137
Mitogenic effects of the up-regulation of MiniChromosome Maintenance proteins (MCM) in anaplastic thyroid carcinoma 133
Molecular profile of hyalinizing trabecular tumors of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations 131
Monitoring training in non-professional soccer players by coupling SSGs and GPS technology: effects of pitch size and players role 130
Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas 129
Pros and cons of cellular studies in developing new drugs for thyroid cancers 127
Molecular biology of the MEN2 gene 127
miR-622 Is a Novel Potential Biomarker of Breast Carcinoma and Impairs Motility of Breast Cancer Cells Through Targeting NUAK1 Kinase 123
Frequent mutation of PIK3CA in Anaplastic Thyroid Cancer 121
Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display 119
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype 115
Regular football training down-regulates miR-1303 muscle expression in veterans 110
Adiponectin and leptin exert antagonizing effects on proliferation and motility of papillary thyroid cancer cell lines 110
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussia post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant 106
Effects of Annurca Flesh Apple Polyphenols in Human Thyroid Cancer Cell Lines 99
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes 94
The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein 92
Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma 91
miR-331-5p Affects Motility of Thyroid Cancer Cell Lines and Regulates BID Expression 83
Preclinical Imaging Evaluation of miRNAs' Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review 71
The lncRNA TEX41 is upregulated in pediatric B-Cells Acute Lymphoblastic Leukemia and it is necessary for leukemic cell growth 64
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 50
Insight into the Role of the miR-584 Family in Human Cancers 46
Exercise’s impact on lung cancer molecular mechanisms: a current overview 43
Association of radiomic features with genomic signatures in thyroid cancer: a systematic review. 34
Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting 1
Totale 11.511
Categoria #
all - tutte 43.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.359


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020216 0 0 0 0 0 0 0 0 0 58 115 43
2020/20211.740 104 140 173 123 147 85 148 51 74 154 50 491
2021/2022783 53 140 26 199 16 24 108 53 71 41 47 5
2022/20231.485 144 91 140 172 229 216 56 161 159 44 55 18
2023/2024390 29 29 34 23 11 48 19 14 79 23 26 55
2024/20252.510 60 230 36 60 34 293 624 987 148 38 0 0
Totale 11.511